Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 29 Aug 05 20FR12G/A Initial registration of securities (foreign private issuers) (amended)
-
23 Aug 05 20FR12G/A Initial registration of securities (foreign private issuers) (amended)
- 10 Aug 05 20FR12G/A Initial registration of securities (foreign private issuers) (amended)
- 14 Jul 05 20FR12G Initial registration of securities (foreign private issuers)
- 12 May 05 20FR12G Initial registration of securities (foreign private issuers)
XTLB similar filings
Filing view
External links
Consent of Independent Registered Public Accounting Firm
The Board of Directors
XTL Biopharmaceuticals Ltd.
We consent to the use in the Annual Report on Form 20-F of XTL Biopharmaceuticals Ltd., filed with the United States Securities and Exchange Commission, of our report dated May 3, 2005 on the consolidated balance sheets of XTL Biopharmaceuticals Ltd., and its subsidiary at December 31, 2004 and the consolidated statements of income, retained earnings and changes in financial position for the years ended December 31, 2004, 2003 and 2002.
/s/ Kesselman & Kesselman
Kesselman & Kesselman
Certified Public Accountant (Isr.)
A member of PricewaterhouseCoopers
International Limited
Tel Aviv, Israel
August 22, 2005